We are live on ! Find out more
TCM

Tetrem Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 16.55%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+16.55%
3 Year Est. Return
+11.29%
5 Year Est. Return
10 Year Est. Return
AUM
$2.66B
AUM Growth
+$83.5M
Cap. Flow
-$44M
Cap. Flow %
-1.65%
Top 10 Hldgs %
38.46%
Holding
65
New
1
Increased
26
Reduced
31
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33.5M
2
CCI icon
Crown Castle
CCI
+$26.6M
3
ETN icon
Eaton
ETN
+$22.9M
4
SU icon
Suncor Energy
SU
+$16.4M
5
RY icon
Royal Bank of Canada
RY
+$15.2M

Sector Composition

Rank Sector Weight
1 Financials 32.15%
2 Energy 13.94%
3 Industrials 11.3%
4 Healthcare 11.04%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
51
Republic Services
RSG
$64.5B
$1.84M 0.07%
36,542
+215
+0.6% +$11K
GE icon
52
GE Aerospace
GE
$391B
$452K 0.02%
3,181
+286
+10% +$42.7K
XOM icon
53
ExxonMobil
XOM
$643B
$451K 0.02%
5,167
+873
+20% +$77.5K
LMT icon
54
Lockheed Martin
LMT
$135B
$418K 0.02%
1,743
+35
+2% +$8.76K
KMB icon
55
Kimberly-Clark
KMB
$35.7B
$400K 0.02%
3,169
+1,075
+51% +$139K
PEP icon
56
PepsiCo
PEP
$191B
$400K 0.02%
3,679
+1,009
+38% +$109K
ADM icon
57
Archer Daniels Midland
ADM
$37.6B
$397K 0.01%
9,422
+325
+4% +$14.1K
SYY icon
58
Sysco
SYY
$40.7B
$385K 0.01%
7,862
-207
-3% -$10.6K
AEP icon
59
American Electric Power
AEP
$69.9B
$375K 0.01%
5,845
+292
+5% +$19.6K
BCR
60
DELISTED
CR Bard Inc.
BCR
$224K 0.01%
1,000
ACN icon
61
Accenture
ACN
$101B
$210K 0.01%
1,715
-693
-29% -$78.9K
MCK icon
62
McKesson
MCK
$96.8B
-88,241
Closed -$16.5M
TEVA icon
63
Teva Pharmaceuticals
TEVA
$40.2B
-705,257
Closed -$35.4M
URI icon
64
United Rentals
URI
$69.5B
-484,995
Closed -$32.5M
POT
65
DELISTED
Potash Corp Of Saskatchewan
POT
-896,323
Closed -$14.6M

Similar funds

Tetrem Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Tetrem Capital Management held 65 positions worth $2.66B, up 3.2% from $2.58B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tetrem Capital Management's Q3 2016 filing shows 1 new, 26 increased, 31 reduced and 4 closed positions. Its largest new stake was Gilead Sciences: 412,773 shares worth $32.7M. The largest sale was Teva Pharmaceuticals, an estimated $35.4M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 32% a quarter earlier, followed by Energy and Industrials.

  • Tetrem Capital Management's largest Q3 2016 buy was Gilead Sciences: 412,773 shares worth $32.7M.
  • Tetrem Capital Management added most to Crown Castle in Q3 2016, an estimated $26.6M increase.
  • Tetrem Capital Management's biggest Q3 2016 reduction was Manulife Financial, cutting an estimated $23.5M.
  • Tetrem Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $35.4M.
  • Tetrem Capital Management's ten largest holdings make up 38% of its $2.66B portfolio in Q3 2016.
  • Tetrem Capital Management opened 1 new position and closed 4 in Q3 2016.
  • Tetrem Capital Management's portfolio value rose 3.2% quarter-over-quarter to $2.66B.

Based on Tetrem Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.